The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, today announced the appointment ...

Sanara is exiting 2024 while demonstrating strong underlying year-over-year organic growth of 37%. Read my most recent ...

Rose brings medical device leadership and commercialization expertise to the company as it prepares to enter into U.S. and European pivotal clinical trials of UroActive, the first smart automated arti ...

Orion Corporation ("Orion"), a globally operating pharmaceutical company, and Invenra Inc., an innovative biotechnology company with proprietary technologies for discovering novel therapeutics, today ...

Archer Aviation (ACHR) has soared 81% over the past year, significantly outperforming benchmark indices. As the maker of the ...

TAMPA, FL / ACCESS Newswire / January 30, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC:CTTH) has submitted a grant to the National Institutes of Health (NIH) that will aid in further research and ...

Zhaoke Ophthalmology Limited is responsible for developing and obtaining regulatory approval for NVK-002 in Greater China, ...

The new patent application covers a multi-functional process that integrates several off-the-shelf devices, including (an) extruder(s), for effective implementation and scaleup of Aduro ...

Many companies and investors believe that AI has to potential to reshape various elements of the pharma industry. Two ...

AmplifyBio, a leading preclinical CRO and CDMO played a pivotal role in shaping discussions at Phacilitate’s Advanced Therapy ...

Molson Coors Beverage Company and Fever-Tree have announced a strategic partnership to expand Molson Coors’ non-alcoholic portfolio in the US.

More than 100 projects have received support as part of the 2024 European Research Council (ERC) proof of concept competition ...